DE1239292B - Process for the preparation of guanylhydrazones of araliphatic carbonyl compounds - Google Patents
Process for the preparation of guanylhydrazones of araliphatic carbonyl compoundsInfo
- Publication number
- DE1239292B DE1239292B DE1964F0042767 DEF0042767A DE1239292B DE 1239292 B DE1239292 B DE 1239292B DE 1964F0042767 DE1964F0042767 DE 1964F0042767 DE F0042767 A DEF0042767 A DE F0042767A DE 1239292 B DE1239292 B DE 1239292B
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- carbon atoms
- guanylhydrazones
- branched
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 10
- 150000001728 carbonyl compounds Chemical class 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 125000002723 alicyclic group Chemical group 0.000 claims description 7
- 125000003118 aryl group Chemical group 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 claims description 5
- 230000003000 nontoxic effect Effects 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 150000007857 hydrazones Chemical class 0.000 claims description 4
- 150000002431 hydrogen Chemical group 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 150000001299 aldehydes Chemical class 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical class NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims description 2
- 239000007859 condensation product Substances 0.000 claims description 2
- 150000001912 cyanamides Chemical class 0.000 claims description 2
- 150000002429 hydrazines Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 150000003583 thiosemicarbazides Chemical class 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- -1 aromatic-heterocyclic aldehydes Chemical class 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- OTXHZHQQWQTQMW-UHFFFAOYSA-N (diaminomethylideneamino)azanium;hydrogen carbonate Chemical compound OC([O-])=O.N[NH2+]C(N)=N OTXHZHQQWQTQMW-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 230000009090 positive inotropic effect Effects 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 108091006112 ATPases Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 2
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- UFEURQXVJUNYBY-UHFFFAOYSA-N 2-[2-(2-oxoethyl)phenyl]acetaldehyde Chemical compound O=CCC1=CC=CC=C1CC=O UFEURQXVJUNYBY-UHFFFAOYSA-N 0.000 description 1
- PGNIGPBGFASMIA-UHFFFAOYSA-N 4-[5-(3-oxobutyl)-1h-pyrrol-2-yl]butan-2-one Chemical compound CC(=O)CCC1=CC=C(CCC(C)=O)N1 PGNIGPBGFASMIA-UHFFFAOYSA-N 0.000 description 1
- NNLUAMSJJVSNAR-UHFFFAOYSA-N 4-methyl-4-[4-(2-methyl-4-oxopentan-2-yl)phenyl]pentan-2-one Chemical compound CC(CC(C)=O)(C)C1=CC=C(C=C1)C(CC(C)=O)(C)C NNLUAMSJJVSNAR-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000005521 carbonamide group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- FBBDOOHMGLLEGJ-UHFFFAOYSA-N methane;hydrochloride Chemical compound C.Cl FBBDOOHMGLLEGJ-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- MXWHMTNPTTVWDM-NXOFHUPFSA-N mitoguazone Chemical group NC(N)=N\N=C(/C)\C=N\N=C(N)N MXWHMTNPTTVWDM-NXOFHUPFSA-N 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
AUSLEGESCHRIFTEDITORIAL
Int. Cl.:Int. Cl .:
C07cC07c
C07dC07d
Deutsche Kl.: 12 ο-17/04 German class: 12 ο -17/04
Nummer:
Aktenzeichen:
Anmeldetag:
Auslegetag;Number:
File number:
Registration date:
Display day;
1239292
F42767IVb/12o
30. April 1964
27. April 19671239292
F42767IVb / 12o
April 30, 1964
April 27, 1967
Aus 4en deutschen Patentschriften 943 408, 958 832 und 963 513 sind Verfahren zur Herstellung von Guanylhydrazonen aliphatischer, aromatischer und aromatisch-heterocyclischer Aldehyde bzw. Ketone bekannt. Diese Verbindungen eignen sich zur Bekämpfung bakterieller Infektionen.From 4en German patents 943 408, 958 832 and 963 513 are processes for the production of Guanylhydrazones of aliphatic, aromatic and aromatic-heterocyclic aldehydes or ketones known. These compounds are useful in combating bacterial infections.
Die Erfindung betrifft ein Verfahren zur Herstellung von Guanylhydrazonen araliphatischer Carbonylverbindungen bzw. deren Salzen mit nichttoxischen Säuren, das dadurch gekennzeichnet ist, daß man Verbindungen mit mehr als einer Aldehyd- bzw. Ketocarbonylgruppe, in welchen zwei Carbonylgruppen durch einen aromatischen Ring und 3 oder mehr Kohlenstoffatome voneinander getrennt sind, in jeweils an sich bekannter Weise entwederThe invention relates to a process for the preparation of guanylhydrazones of araliphatic carbonyl compounds or their salts with non-toxic acids, which is characterized in that one compounds with more than one aldehyde or ketocarbonyl group in which two carbonyl groups are separated from each other by an aromatic ring and 3 or more carbon atoms, in a manner known per se either
a) mit Aminoguanidinen der allgemeinen Formel H2N-N-C-NHBa) with aminoguanidines of the general formula H 2 NNC-NHB
Verfahren zur Herstellung von
Guanylhydrazonen araliphatischer
CarbonylverbindungenProcess for the production of
Guanylhydrazones more araliphatic
Carbonyl compounds
Anmelder:Applicant:
Farbenfabriken Bayer Aktiengesellschaft,Paint factories Bayer Aktiengesellschaft,
LeverkusenLeverkusen
Als Erfinder benannt:Named as inventor:
Dr. Siegismund Schütz,Dr. Siegismund Schütz,
Dr. Karlheinz Meyer, Wuppertal-Elberfeld;Dr. Karlheinz Meyer, Wuppertal-Elberfeld;
Dr. Kurt Stoepel, Wuppertal-Vohwinkel;Dr. Kurt Stoepel, Wuppertal-Vohwinkel;
Dr. Hans-Günther Kroneberg,Dr. Hans-Günther Kroneberg,
Wuppertal-ElberfeldWuppertal-Elberfeld
E NAE NA
oder deren Salzen umsetzt oder b) mit Thiosemicarbaziden der allgemeinen Formelor reacts their salts or b) with thiosemicarbazides of the general formula
H2N-N-C-NH-BH 2 NNC-NH-B
kondensiert und die Kondensationsprodukte entweder direkt oder nach ihrer Überführung in S-Alkylisotbiosemicarbazone mit Aminen der allgemeinen Formelcondensed and the condensation products either directly or after their conversion into S-alkylisotbiosemicarbazones with amines of the general formula
H2N-AH 2 NA
umsetzt oderimplements or
c) mit S-Alkylisothiosemicarbaziden der allgemeinen Formelc) with S-alkylisothiosemicarbazides of the general formula
H2N-N-C = NAH 2 NNC = NA
E S — AlkylE S - alkyl
kondensiert und die erhaltenen Produkte mit Aminen der allgemeinen Formelcondensed and the products obtained with amines of the general formula
H2N-BH 2 NB
umsetzt oderimplements or
d) mit Hydrazinen der allgemeinen Formeld) with hydrazines of the general formula
HiN-NHHiN-NH
E
kondensiert und die erhaltenen Hydrazone mit Cyanamiden der allgemeinen FormelE.
condensed and the hydrazones obtained with cyanamides of the general formula
N=C-NH-BN = C-NH-B
oder S-Alkylisothioharnstoffen der allgemeinen Formelor S-alkylisothioureas in general formula
NAN / A
;.
Alkyl — S — C — NHB;.
Alkyl - S - C - NHB
umsetztimplements
und die erhaltenen Guanylhydrazone als solche oder in Form ihrer Salze mit nichttoxischen Säuren isoliert.and the guanylhydrazones obtained are isolated as such or in the form of their salts with non-toxic acids.
In den vorstehend angegebenen Formeln stehen AIn the formulas given above, A stands
und E für Wasserstoff oder einen verzweigten oder unverzweigten aliphatischen oder einen alicyclischen Rest mit jeweils 1 bis 6 Kohlenstoffatomen, die eine oder mehrere Hydroxylgruppen tragen können. B bedeutet Wasserstoff, einen unsubstituierten oder mit einer oder mehreren Hydroxylgruppen substituierten alicyclischen oder verzweigten oder unyerzweigten aliphatischen Rest mit jeweils 1 bis 6 Kohlenstoffatomen, wobei dieser Rest auch, gegebenenfalls über ein Stickstoff-, Sauerstoff- oder Schwefelatom, mit A verbunden sein kann, eine Nitro- oder eine Aminogruppe oder einen basischen Rest D. D steht für einen Rest der allgemeinen Formeland E represents hydrogen or a branched or unbranched aliphatic or an alicyclic Remainder with 1 to 6 carbon atoms each, which can carry one or more hydroxyl groups. B means Hydrogen, an unsubstituted or substituted by one or more hydroxyl groups alicyclic or branched or unbranched aliphatic radical with 1 to 6 carbon atoms each, this radical also, optionally via a nitrogen, oxygen or sulfur atom, with A may be linked, a nitro or an amino group or a basic radical D. D stands for a Remainder of the general formula
,R, R
709 577/362709 577/362
in der « = O bis 8 und /1 oder 2 sein kann und R und R1 jeweils für Wasserstoff, für gleiche oder verschiedene, unsubstituierte, mit einer oder mehreren OH-Gruppen substituierte, alicyclische oder verzweigte oder unverzweigte aliphatische Reste mit jeweils bis zu 6 Kohlenstoffatomen, die, gegebenenfalls auch über ein Stickstoff-, Schwefel- oder Sauerstoffatom, miteinander verbunden sein können, stehen.in which «= 0 to 8 and / 1 or 2 and R and R 1 each represent hydrogen, for identical or different, unsubstituted, alicyclic or branched or unbranched aliphatic radicals each with up to 6 carbon atoms, which, if appropriate, can also be connected to one another via a nitrogen, sulfur or oxygen atom.
Die an den aromatischen Ring, bei dem es sich auch um einen Heterocyclus handeln kann, ankondensierten Ketten, deren Carbonylgruppen in dieGuanylhydrazongruppierungen übergeführt werden, können beliebig lang, gesättigt oder ungesättigt, verzweigt oder unverzweigt, durch Stickstoff-, Sauerstoff- und/ oder Schwefelatome sowie alicyclische, aromatische oder heterocyclische Ringe unterbrochen sowie durch OH, O — Acyl, O — Alkyl, O — Alkenyl, O — Alkinyl, Carboxyl, Halogen, CN, NRR1, Cycloalkyl, Aryl, Aralkyl und Heterocyclen substituiert sein.The chains fused to the aromatic ring, which can also be a heterocycle, the carbonyl groups of which are converted into the guanylhydrazone groups, can be of any length, saturated or unsaturated, branched or unbranched, by nitrogen, oxygen and / or sulfur atoms as well alicyclic, aromatic or heterocyclic rings and substituted by OH, O-acyl, O-alkyl, O-alkenyl, O-alkynyl, carboxyl, halogen, CN, NRR 1 , cycloalkyl, aryl, aralkyl and heterocycles.
Der aromatische Ring kann durch Halogen, Alkyl, NRR1, NO2, OH, O — Acyl, O —· Alkyl, O — Alkenyl, Cycloalkyl, CN, SO2R, Carbonyl, Carbonamid, Heterocyclen und Alicyclen substituiert sein und/oder ankondensierte alicyclische und heterocyclische nichtaromatische Ringe besitzen. asThe aromatic ring can be substituted by halogen, alkyl, NRR 1 , NO 2 , OH, O - acyl, O - · alkyl, O - alkenyl, cycloalkyl, CN, SO 2 R, carbonyl, carbonamide, heterocycles and alicyclics and / or have fused alicyclic and heterocyclic non-aromatic rings. as
Geeignete Ausgangsmaterialien für das erfindungsgemäße Verfahren sind z. B. l,4-Bis-(/3-acetyl-athyl)-benzol, 1,3 - Bis - (ß - acetyl - äthyl) - benzol, 1,4 - Bis- (ß - acetyl - vinyl) - benzol, 1,3 - Bis - (ß - acetyl - vinyl)-benzol, 4-(ß- Benzoyl - vinyl) - benzaldehyd, 1,4 - Bis- (ß - benzoyl - äthyl) - benzol, 1,4 - Bis - (ß - benzoylpropyl) - benzol, 1,4 - Bis - (ß - ρ - toluyl - äthyl) - benzol, 1,4 - Bis - (ß - benzoyl - vinyl) - benzol, 1,4 - Bis- (ß - benzoyl - propenyl) - benzol, 1,4 - Bis - (ß - ρ - toluyl - vinyl) - benzol, ß,ß' - ρ - Phenylen - diacrolein, 1,1' - ρ - Phenylen - di - [pentadien - (1,3) - al - (5)], 1,2 - Phenylen - diacet - aldehyd, 2,5 - Furan - β,β' - dipropion - aldehyd, 2,5 - Bis - (ß - acetyl - äthyl) - thiophen, 4,4' - (p - Phenylen) - bis - [4 - methyl - 2 - pentanon]. Suitable starting materials for the process according to the invention are, for. B. l, 4-bis - (/ 3-acetyl-ethyl) benzene, 1,3 - bis - (ß - acetyl - ethyl) - benzene, 1,4 - bis (ß - acetyl - vinyl) - benzene , 1,3 - bis (ß - acetyl - vinyl) benzene, 4- (ß - benzoyl - vinyl) - benzaldehyde, 1,4 - bis (ß - benzoyl - ethyl) - benzene, 1,4 - bis - (ß - benzoylpropyl) - benzene, 1,4 - bis - (ß - ρ - toluyl - ethyl) - benzene, 1,4 - bis - (ß - benzoyl - vinyl) - benzene, 1,4 - bis ( ß - benzoyl - propenyl) - benzene, 1,4 - bis - (ß - ρ - toluyl - vinyl) - benzene, ß, ß ' - ρ - phenylene - diacrolein, 1,1' - ρ - phenylene - di - [ pentadiene - (1,3) - al - (5)], 1,2 - phenylene - diacet - aldehyde, 2,5 - furan - β, β ' - dipropion - aldehyde, 2,5 - bis - (ß - acetyl - ethyl) - thiophene, 4,4 '- (p - phenylene) - bis - [4 - methyl - 2 - pentanone].
Die erfindungsgemäß herstellbaren Guanylhydrazone wirken ähnlich wie Herzglycoside, d. h., sie steigern die Kontraktionskraft der Herzmuskulatur. Gleichartig wirkende synthetisch herstellbare Verbindungen sind bisher nicht bekannt.The guanylhydrazones which can be prepared according to the invention act similarly to cardiac glycosides, i.e. i.e., they increase the force of contraction of the heart muscles. Similar acting synthetically producible compounds are not yet known.
Die Verfahrensprodukte sind anwendbar als solche oder in Form ihrer Salze mit nichttoxischen organischen oder anorganischen Säuren. Geeignete Säuren sind z. B. Essigsäure, Propionsäure, Milchsäure, Maleinsäure, Fumarsäure, Bernsteinsäure, Weinsäure, Zitronensäure, Salicylsäure, Naphthalin-l,5-disulfonsäure, Phosphorsäure, Salzsäure.The products of the process can be used as such or in the form of their salts with non-toxic organic substances or inorganic acids. Suitable acids are e.g. B. acetic acid, propionic acid, lactic acid, Maleic acid, fumaric acid, succinic acid, tartaric acid, citric acid, salicylic acid, naphthalene-l, 5-disulfonic acid, Phosphoric acid, hydrochloric acid.
Die Erzeugnisse des erfindungsgemäßen Verfahrens besitzen eine positiv inotrope Herzmuskelwirkung, welche durch die folgenden pharmakologischen Ver-Suchsanordnungen nachgewiesen wird:The products of the method according to the invention have a positive inotropic cardiac muscle effect, which is proven by the following pharmacological test arrangements:
1. Isoliertes spontan schlagendes Herzvorhofspräparat des Meerschweinchens. Methode s. P-Holtz und E. Westermann, Naunyn-Schnuede- , bergs Arch. exp. Path. u. Pharmak., 225, S. 421 (1955), sowie G. K r ο η e b e r g und K. S t ο epel, Naunyn-Schmiedebergs Arch. exp. Path.1. Isolated spontaneously beating atrial preparation of the guinea pig. Method see P-Holtz and E. Westermann, Naunyn-Schnuede-, bergs Arch. exp. Path. and Pharmak., 225, p. 421 (1955), as well as G. K rο η e b e r g and K. S tο epel, Naunyn-Schmiedebergs Arch. Exp. Path.
Γι Pharmak
u. rnarmaK.,Γι Pharmak
u. rnarmaK.,
2. Isoliertes Froschherz nach Sträub. Methode s. H. F r ü h η e r, Nachweis und Bestimmung von Giften auf biol. Wege, Urban und Schwarzenberg, Berlin—Wien (1911), S. 123 bis 129.2. Isolated frog heart according to Sträub. method s. H. F r ü h η e r, detection and determination of poisons on biol. Paths, Urban and Schwarzenberg, Berlin-Vienna (1911), pp. 123 to 129.
3. Hemmung der Transport-ATPase des Meerschweinchenherzens
(K. R e ρ k e und H. J. P ο rt i u s , Experientia, 19, S. 452 [1963]).
Gewinnung der Transport-ATPase nach T. K ο η ο und S. P. Collowick, Arch. Biochem. Biophys.,
93, S. 520 bis 533 (1961). Bestimmung der Enzymaktivität nach J. V. Auditore, Proc.
Soc. exp. Biol. Med., 110, S. 595 bis 597 (1962).3. Inhibition of the transport ATPase of the guinea pig heart (K. R e ρ ke and HJ P ο rt ius, Experientia, 19, p. 452 [1963]).
Obtaining the transport ATPase according to T. Kο η ο and SP Collowick, Arch. Biochem. Biophys., 93, pp. 520-533 (1961). Determination of the enzyme activity according to JV Auditore, Proc. Soc. exp. Biol. Med., 110, pp. 595-597 (1962).
Untersuchungsergebnisse
Bisguanylhydrazon-dihydrochlorid
des W-Bis-^-acetylvmyO-benzolsInvestigation results
Bisguanyl hydrazone dihydrochloride
des W-Bis - ^ - acetylvmyO-benzene
Toxizität, MausToxicity, mouse
12,0 bis 16,0 mg/kg i. v.12.0 to 16.0 mg / kg i.p. v.
Herzvorhof, MeerschweinchenAtrium, guinea pigs
Positiv inotrope Wirkung ab Konzentrationen von 3 · 10~e g/ml. Herzmuskelkontraktur und Stillstand bei Konzentrationen von 3 · 10~B g/ml.Positive inotropic effect from concentrations of 3 · 10 ~ e g / ml. Cardiac muscle contracture and arrest at concentrations of 3 x 10 ~ B g / ml.
FroschherzFrog heart
Positiv inotrope Wirkung und systolischer Herzstillstand ab Konzentrationen von lO-^g/ml.Positive inotropic effects and systolic cardiac arrest from concentrations of 10- ^ g / ml.
Transport-ATPase, MeerschweinchenTransport ATPase, guinea pig
Bei Konzentrationen von 10~5molar = 23%Hemmung. At concentrations of 10 ~ 5 molar = 23% inhibition.
Bisguanylhydrazon-dihydrochloridBisguanyl hydrazone dihydrochloride
des M -P-Phenylendmcrolems
Toxizität, Maus of M- P-phenylendmcrolem
Toxicity, mouse
10,0 bis 12,5 mg/kg i. v.
Herzvorhof, Meerschweinchen10.0 to 12.5 mg / kg iv
Atrium, guinea pigs
Positiv inotrope Wirkung ab Konzentrationen von 3 · 10~5 g/ml. Herzmuskelkontraktur ab Konzentrationen
von 10~5 g/ml.
FroschherzPositive inotropic effect from concentrations of 3 · 10 ~ 5 g / ml. Heart muscle contracture from concentrations of 10 ~ 5 g / ml.
Frog heart
Positiv inotrope Wirkung und systolischer Herzstillstand ab Konzentrationen von 0,5 · 10~4 g/ml. Die folgenden Beispiele erläutern die Erfindung.Positive inotropic effects and systolic cardiac arrest from concentrations of 0.5 · 10 ~ 4 g / ml. The following examples illustrate the invention.
4 g 1,4 - Bis - [ß - (p - chlor - benzoyl) - vinyl] - benzol werden in 600 ml Chloroform gelöst, mit 300 ml Äthanol verdünnt und nach Zugabe einer Lösung von 3 g Aminoguanidin-hydrogencarbonat in methanolischer Salzsäure (pH-Wert = 2) 3 Tage unter Stickstoff bei Raumtemperatur aufbewahrt. Man engt im Vakuum auf 150 ml ein, rührt die Lösung in Äther ein, saugt die ausfallenden Flocken ab und kocht sie mit wenig Äthanol aus.4 g of 1,4 - bis - [ß - (p - chloro - benzoyl) - vinyl] - benzene are dissolved in 600 ml of chloroform, diluted with 300 ml of ethanol and, after adding a solution of 3 g of aminoguanidine hydrogen carbonate in methanolic hydrochloric acid ( pH value = 2) Stored for 3 days under nitrogen at room temperature. It is concentrated in vacuo to 150 ml, the solution is stirred into ether, the flakes which precipitate are filtered off with suction and boiled with a little ethanol.
Man erhält 3 g Dihydrochlorid des 1,4 - Bis[/3-(p-chlor-benzoyl)-vinyl]-benzolbisguanylhydrazons, Fp. 256 bis 26O0C (Zersetzung).To give 3 g of the dihydrochloride 1.4 -. Bis [/ 3- (p-chloro-benzoyl) -vinyl] -benzolbisguanylhydrazons, mp 256 to 26O 0 C (decomposition).
Analog wird hergestellt: Dihydrochlorid des 1,4-Bis-(|S-acetyl-vinyl)-benzolbisguanylhydrazons, Fp. 320° C (Zersetzung).The following is prepared analogously: dihydrochloride of 1,4-bis- (| S-acetyl-vinyl) -benzolbisguanylhydrazone, Mp. 320 ° C (decomposition).
2 i^ßis-OS-acetyl-äthyO-benzol werden in 100 ml f hano1 8^- ™ einer Losung von 2 5 g 2 i ^ ßis-OS-acetyl-äthyO-benzene are in 100 ml of f hano1 8 ^ - ™ a solution of 2 5 g
Aminoguanidin-hydrogencarbonat m methanohscher Salzsaure vom pH-Wert = 2 versetzt. Man laßt 3 Tage unter Stlckstoff bei Raumtemperatur stehen, rührt in Äther ^ gaugt den Niederschlag ab und kristallisiert aus Alkohol um.Aminoguanidine hydrogen carbonate mixed with methane hydrochloric acid with a pH of 2. The mixture is left to stand for 3 days under solid material at room temperature, the precipitate is filtered off with suction in ether and recrystallized from alcohol.
Man erhält 2 g Dihydrochlorid des l,4-Bis-(^-acetyläthyl)-benzolbisguanylhydrazons, Fp. 198 bis 200° C (Zersetzung).2 g of dihydrochloride of 1,4-bis (^ - acetylethyl) -benzolbisguanylhydrazone are obtained, Mp 198 to 200 ° C (decomposition).
3,7 g jS.jS'-p-Phenylen-diacrolein werden in Methanol gelöst und mit einer Lösung von 6 g Aminoguanidinhydrogencarbonat in methanolischer Salzsäure versetzt und bei Zimmertemperatur (pH = 3) bis zur Beendigung der Reaktion gerührt. Anschließend fällt man durch Eintragen in Äther aus, trennt den ausfallenden Niederschlag ab, behandelt ihn mit Aceton und fällt aus Methanol—Äther um.3.7 g of jS.jS'-p-phenylenediacrolein are dissolved in methanol dissolved and treated with a solution of 6 g of aminoguanidine hydrogen carbonate in methanolic hydrochloric acid and stirred at room temperature (pH = 3) until the reaction has ended. Afterward if one precipitates by introducing it into ether, the precipitate which separates out is separated off and treated with it Acetone and precipitates from methanol-ether.
Man erhält 4,5 g Dihydrochlorid des ß/S'-p-Phenylen-diacroleinbisguanylhydrazonsvomSchmelzpunkt 249 bis 25O0C.This gives 4.5 g of the dihydrochloride ß / S'-p-phenylene-diacroleinbisguanylhydrazonsvomSchmelzpunkt 249 to 25O 0 C.
In analoger Weise erhält man Dihydrochlorid des 1,1' - ρ - Phenylen - bis - [pentadien - (1,3 - al - (5) - bisguanylhydrazone], F. >360°C; Tetrahydrochlorid des ß,ß' - ρ - Phenylen - diacroleinbis - [1 - (ß - diäthylamino-äthyl)-guanylhydrazons], F. 170 bis 175°C.In an analogous manner, dihydrochloride of 1,1 '- ρ - phenylene - bis - [pentadiene - (1,3 - al - (5) - bisguanylhydrazones], melting point> 360 ° C; tetrahydrochloride of β, ß' - ρ is obtained - Phenylene - diacroleinbis - [1 - (ß - diethylamino-ethyl) -guanylhydrazone], mp 170 to 175 ° C.
7 g Aminoguanidin-hydrogencarbonat werden in methanolischer Salzsäure bis zum pH-Wert = 2 gelöst, mit einer Lösung von 5 g 2,5-Bis-(/?-acetyläthyl)-furan in 10 ml Äthanol versetzt und 3 Tage unter N2 bei Raumtemperatur aufbewahrt. Man rührt in Äther ein, ^dekantiert, kocht den zähen Rückstand mit wenig Äthanol auf, saugt die entstehenden Kristalle ab und kristallisiert aus Äthanol um.7 g of aminoguanidine hydrogen carbonate are dissolved in methanolic hydrochloric acid to pH = 2, mixed with a solution of 5 g of 2,5-bis (/? - acetylethyl) -furan in 10 ml of ethanol and added for 3 days under N 2 Stored at room temperature. The mixture is stirred into ether and decanted, the viscous residue is boiled up with a little ethanol, the crystals formed are filtered off with suction and recrystallized from ethanol.
Man erhält 6 g Dihydrochlorid des 2,5-Bis-[(/S-acetyläthyl)-furan-guanylhydrazons], Fp. 1000C.This gives 6 g of the dihydrochloride of 2,5-bis -. [(/ S-acetyläthyl) -furan-guanylhydrazons], mp 100 0 C.
Analog Beispiel 4 erhält man, ausgehend vom 2,5 - Bis - (ß - acetyl - äthyl) - pyrrol, das Dihydrochlorid des 2,5-Bis-[(/5-acetyl-äthyl)-pyrrol-guanylhydrazons], Fp. 152° C (Zersetzung).Analogously to Example 4, starting from 2,5- bis- (β -acetyl-ethyl) -pyrrole, the dihydrochloride of 2,5-bis- [(/ 5-acetyl-ethyl) -pyrrole-guanylhydrazone], mp. 152 ° C (decomposition).
Claims (1)
E S i
IT
umsetzt oderH 2 NA
implements or
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1964F0042767 DE1239292B (en) | 1964-04-30 | 1964-04-30 | Process for the preparation of guanylhydrazones of araliphatic carbonyl compounds |
| GB1810565A GB1036987A (en) | 1964-04-30 | 1965-04-29 | New guanyl hydrazones |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1964F0042767 DE1239292B (en) | 1964-04-30 | 1964-04-30 | Process for the preparation of guanylhydrazones of araliphatic carbonyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1239292B true DE1239292B (en) | 1967-04-27 |
Family
ID=7099242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1964F0042767 Pending DE1239292B (en) | 1964-04-30 | 1964-04-30 | Process for the preparation of guanylhydrazones of araliphatic carbonyl compounds |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE1239292B (en) |
| GB (1) | GB1036987A (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4154947A (en) * | 1978-03-13 | 1979-05-15 | American Cyanamid Company | Heterocyclic substituted benzylideneaminoguanidines |
| US5612332A (en) * | 1984-03-19 | 1997-03-18 | Alteon Inc. | Di- and triaminoguanidines, and methods of use |
| US5852009A (en) * | 1984-03-19 | 1998-12-22 | The Rockefeller University | Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon |
| US4983604A (en) * | 1987-11-13 | 1991-01-08 | The Rockefeller University | Inhibitors of nonenzymatic cross-linking |
| US5850840A (en) * | 1995-11-15 | 1998-12-22 | Alteon Inc. | Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| US5877217A (en) * | 1995-12-26 | 1999-03-02 | Alteon Inc. | N-acylaminoalkyl-hydrazinecarboximidamides |
| US6110968A (en) * | 1995-12-26 | 2000-08-29 | The Picower Institute For Medical Research | Methods for treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
-
1964
- 1964-04-30 DE DE1964F0042767 patent/DE1239292B/en active Pending
-
1965
- 1965-04-29 GB GB1810565A patent/GB1036987A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1036987A (en) | 1966-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2452691A1 (en) | 2,6-DISUBSTITUTED PHENYLAMINOGUANIDINE COMPOUNDS | |
| DE1239292B (en) | Process for the preparation of guanylhydrazones of araliphatic carbonyl compounds | |
| DE2455353A1 (en) | SUBSTITUTED ALPHA-AMINOOXYCARBONIC ACID HYDRACIDE DERIVATIVES AND THEIR ACID ADDITIONAL SALTS AND THEIR USE AND METHOD OF MANUFACTURING THE SAME | |
| DE1186872B (en) | Process for the preparation of 4-halo-3-sulfamoylbenzoic acid hydrazides | |
| DE1238896B (en) | Process for the preparation of guanylhydrazones of aliphatic carbonyl compounds | |
| DE1229096B (en) | Process for the preparation of 2-substituted 3-amino-pyrazole-4-carboxylic acid-N '- [5-nitrofuryl- (2) -methylidene] -hydrazides | |
| DE1239291B (en) | Process for the preparation of guanyl hydrazone of aromatic polycyclic carbonyl compounds | |
| AT211831B (en) | Process for the preparation of new isoindoline derivatives | |
| AT226693B (en) | Process for the preparation of new α-pyrrolidino-valerophenones | |
| AT261820B (en) | Process for the production of new steroid guanylhydrazones | |
| DE856297C (en) | Process for the production of 3- (2-oxy-phenyl) -pyrazole or its substitution products | |
| AT206899B (en) | Process for the preparation of new, substituted 3,5-dioxo-tetrahydro-1,2,6-thiadiazine-1,1-dioxyden | |
| AT229862B (en) | Process for the preparation of new methylidene compounds | |
| DE1670698C3 (en) | Sulfomamide derivatives and processes for their preparation | |
| AT343664B (en) | PROCESS FOR THE PREPARATION OF NEW AMINOPYRAZOLOISOCHINOLINE DERIVATIVES AND THEIR SALTS | |
| DE964495C (en) | Process for the preparation of a new thiosemicarbazide | |
| DE1745612C (en) | 7 (N chloroalkyl ureido) cephalospo ransauren and their salts and a process for their production | |
| AT234114B (en) | Process for the preparation of new benzenesulfonylureas | |
| AT262964B (en) | Process for the preparation of basic substituted O-ethers of 10,11-dihydro-5H-dibenzo [a, d] cyclohepten-5-one oxime | |
| AT236406B (en) | Process for the preparation of new azidobenzenesulfonylureas | |
| AT231462B (en) | Process for the production of new guanylhydrazones | |
| AT242128B (en) | Process for the preparation of new benzofuryl (3) ethylamines and their salts | |
| DE1593925C (en) | Nitrosohydroxylaminopropionic acid derivatives and process for their preparation | |
| DE2455432A1 (en) | SUBSTITUTED ALPHA-AMINOOXYHYDROXAMIC ACID DERIVATIVES AND THEIR USE AND METHOD FOR MANUFACTURING THE SAME | |
| AT234687B (en) | Process for the production of new benzodioxane derivatives and their acid addition salts |